APOB and atherosclerosis: However, recent advances based on peptide-specific tetramer staining and single-cell transcriptomics have identified CD4+ T cells reactive to native ApoB in murine and human atherosclerosis, challenging the exclusivity of modified ApoB in this process (105, 106).